Metraipolis › archive › dc_eba2178105a8

Dual-Targeted Therapy in Cardiometabolic Risk: A Meta-Analysis of Telmisartan-Based Combinations for Hypertension and Dyslipidemia — Europe PMC PMID:41292423

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41292423
DOI
10.1002/clc.70211
License (as archived)
solo-consultazione
Archived
2026-11-08T02:03:49.715Z
SHA-256 of the archived text
e3db6b61650d275cd2fe5080687a552b49ac073819c79e6f19e554627b9ef0f5
Stable URL of this page
https://metraipolis.com/documento/dc_eba2178105a8

How to cite

Dual-Targeted Therapy in Cardiometabolic Risk: A Meta-Analysis of Telmisartan-Based Combinations for Hypertension and Dyslipidemia — Europe PMC PMID:41292423 — Europe PMC (en), https://europepmc.org/article/MED/41292423 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eba2178105a8 (Metraipolis archive dc_eba2178105a8, sha256 e3db6b61650d275cd2fe5080687a552b49ac073819c79e6f19e554627b9ef0f5)
BibTeX
@misc{dceba2178105a8,
  title = {Dual-Targeted Therapy in Cardiometabolic Risk: A Meta-Analysis of Telmisartan-Based Combinations for Hypertension and Dyslipidemia — Europe PMC PMID:41292423},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41292423},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eba2178105a8; sha256 e3db6b61650d275cd2fe5080687a552b49ac073819c79e6f19e554627b9ef0f5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41292423. Agents can read the archived copy with the MCP tool read_document.